Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Gut|May 13, 2004
Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm CountyT Ljung, P Karlén, D Schmidt, et al.
The Journal of Clinical Endocrinology and Metabolism|July 7, 2005
A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic controlP T Schmidt, E Näslund, P Grybäck, et al.
Acta Physiologica (Oxford, England)|July 16, 2015
Nitric oxide regulation of migrating motor complex: randomized trial of N(G)-monomethyl-L-arginine effects in relation to muscarinic and serotonergic receptor blockadeM A Halim, L Gillberg, S Boghus, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 19, 2002
Gastric emptying and duodeno-gastro-oesophageal reflux in gastro-oesophageal reflux diseaseJ Freedman, P Grybäck, M Lindqvist, et al.
Acta Anaesthesiologica Scandinavica|March 12, 2008
Pre-operative carbohydrate loading may be used in type 2 diabetes patientsU O Gustafsson, J Nygren, A Thorell, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2005
Inhibitory effect of exogenous orexin a on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in manM Ehrström, T Gustafsson, A Finn, et al.
Regulatory Peptides|November 6, 2003
Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satietyP T Schmidt, E Näslund, P Grybäck, et al.
Acta Anaesthesiologica Scandinavica|January 30, 2018
The effects of added whey protein to a pre-operative carbohydrate drink on glucose and insulin responseN Karimian, M Moustafa, J Mata, et al.
Regulatory Peptides|August 5, 2009
Differential effect of PYY1-36 and PYY3-36 on gastric emptying in manA-B Witte, P Grybäck, J J Holst, et al.
Neurogastroenterology and Motility|February 27, 2008
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndromeP M Hellström, E Näslund, T Edholm, et al.
Pageof 15